Position
Entropy Technologies, LP in Aurinia Pharmaceuticals Inc.
Back to the book · All holders of AUPH
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$40.5K$15.95 → $14.82
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 47.7K | $760.8K | — | — | — | 0.0% |
| Q1 2026 | 35.9K | $531.4K | $14.82 | −$40.5K | −$188.9K | 0.0% |